Organon & Co. · NYSE:OGN
Arjona Ferreira Juan Camilo exercised options for 13,431 Organon & Co. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Arjona Ferreira Juan Camilo (Head of R&D & CMO) exercised options for 13,431 Organon & Co. shares, leaving 30,047 shares. Filed Apr 2, 2026 (Form 4).
- Options exercised
- 13,431 shares
- Holding after
- 30,047 shares
- Trading plan
- No
- Role
- Head of R&D & CMO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Option exercise | 13,431 | 34,867 | Direct | |
| Mar 31, 2026 | Common Stock | Shares withheld for tax | 4,820 | US$5.70 | 30,047 | Direct |
Source
Related
- Organon & Co.
- Arjona Ferreira Juan Camilo
- Organon & Co. shareholders
- Form 4 · Arjona Ferreira Juan Camilo · Aug 12, 2026
- Schedule 13G · Pentwater Capital Management LP · Aug 14, 2026
- Form 4 · Drinane Juliana Papa · Aug 5, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4/A · Holzbaur Lynette · May 7, 2026
- Form 4 · Holzbaur Lynette · May 7, 2026